Daily Archives: June 18, 2005

Featured Stories
Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

SUPREME COURT DECISION ALLOWING FEDERAL PROSECUTION FOR THE CULTIVATION AND USE OF MARIJUANA FOR MEDICAL PURPOSES FACES ITS FIRST CHALLENGE AS OREGON RESUMES ITS PROGRAM

The state of Oregon resumed issuing medical-marijuana registration cards after its Attorney General concluded the June 6 ruling by the United States Supreme Court did not invalidate the state’s program.The Human Services Department had continued to process applications but had … Continue reading

Posted in Legal News |

MASTERCARD CONFIRMS THAT MASSIVE THEFT OF PERSONAL DATA HAS EXPOSED 13.9 MILLION OF ITS CREDIT CARDS AND 40 MILLION CREDIT CARDS OF ALL BRANDS TO FRAUD

A massive security breach traced to a third-party processor of payment card data has led MasterCard International Inc. to begin notifying member banks that more than 40 million credit cards of all brands are now potentially exposed to acts of … Continue reading

Posted in Legal News |

CONSUMER PRODUCT SAFETY COMMISSION (CPSC) AND SHAKESPEARE FISHING TACKLE DIVISION ANNOUNCE RECALL OF 438,000 CHILDRENíS FISHING KITS FOR LEAD PAINT HAZARD

The CPSC, in voluntary cooperation with Shakespeare Fishing Tackle Division of Columbia, South Carolina, has announced the recall of 438,000 Children’s Fishing Kits manufactured in China. Consumers should stop using recalled products immediately unless otherwise instructed. The paint on the … Continue reading

Posted in Defective Products |

ABLE LABORATORIES PROBLEMS CONTINUE AS FDA AND QUALITY CARE PRODUCTS LLC ISSUE NATIONWIDE RECALL OF ALL REPACKAGED ABLE DRUG PRODUCTS

On May 27, the FDA ordered the recall of Abel Laboratories’ entire product line. At the same time, Able suspended all manufacturing, withdrew seven approved applications to market various medications, and saw its Chairman and CEO resign. Able Laboratories Inc., … Continue reading

Posted in Defective Products |

FDA ANNOUNCES RECALL OF AccuSure INSULIN SYRINGE 1-cc, 28-Gauge 1/2-Inch 100ís

The Food and Drug Administration (FDA) and Qualitest Pharmaceuticals, Inc., have notified healthcare professionals and consumers via letter of a nationwide recall of all lots of 1-cc, 28 gauge 1/2-inch AccuSure insulin syringes (NDC 0603-6996-21, boxes of 100) distributed between … Continue reading

Posted in Defective Products |

ABLE LABORATORIES PROBLEMS CONTINUE AS FDA AND QUALITY CARE PRODUCTS LLC ISSUE NATIONWIDE RECALL OF ALL REPACKAGED ABLE DRUG PRODUCTS

On May 27, the FDA ordered the recall of Abel Laboratories’ entire product line. At the same time, Able suspended all manufacturing, withdrew seven approved applications to market various medications, and saw its Chairman and CEO resign. Able Laboratories Inc., … Continue reading

Posted in Legal News |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.